Neuroplast

BE Therapeutics

This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.

Savanna Biotherapeutics

This company develops induced pluripotent stem cell-derived microglia cell therapies to treat patients with neurodegenerative diseases and other central nervous system disorders.

NovaGo Therapeutics

This clinical-stage biotechnology company develops human antibody therapeutics to promote nerve regeneration for patients with spinal cord injuries and strokes.

Neurona Therapeutics

This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.

Aspen Neuroscience

This biotechnology firm develops personalised autologous cell therapies to replace damaged neurons in patients with Parkinson's disease.

QurAlis

This company develops precision medicines for patients with amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.

Eikonoklastes Therapeutics

This clinical stage biopharmaceutical company develops gene therapies for patients suffering from amyotrophic lateral sclerosis and other neurodegenerative diseases.

Cellergy Therapeutics

This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.